Oppenheimer Downgrades Northwest Biotherapeutics (NWBO) to Perform
Tweet
Share
E-mailGet Alerts NWBO Hot Sheet
Price: $0.18 -5.26%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Oppenheimer downgraded Northwest Biotherapeutics (NASDAQ: NWBO) from Outperform to Perform and removed its price target (prior $5.00).
For an analyst ratings summary and ratings history on Northwest Biotherapeutics click here. For more ratings news on Northwest Biotherapeutics click here.
Shares of Northwest Biotherapeutics closed at $9.18 yesterday.
For an analyst ratings summary and ratings history on Northwest Biotherapeutics click here. For more ratings news on Northwest Biotherapeutics click here.
Shares of Northwest Biotherapeutics closed at $9.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
- Maxim Group Downgrades cbdMD Inc. (YCBD) to Hold
Create E-mail Alert Related Categories
Downgrades, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
